These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15585856)

  • 1. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses.
    Ghansah T; Paraiso KH; Highfill S; Desponts C; May S; McIntosh JK; Wang JW; Ninos J; Brayer J; Cheng F; Sotomayor E; Kerr WG
    J Immunol; 2004 Dec; 173(12):7324-30. PubMed ID: 15585856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease.
    Paraiso KH; Ghansah T; Costello A; Engelman RW; Kerr WG
    J Immunol; 2007 Mar; 178(5):2893-900. PubMed ID: 17312133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHIP limits immunoregulatory capacity in the T-cell compartment.
    Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG
    Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.
    Pilon-Thomas S; Nelson N; Vohra N; Jerald M; Pendleton L; Szekeres K; Ghansah T
    PLoS One; 2011; 6(11):e27729. PubMed ID: 22132131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
    Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
    J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
    Kleindienst P; Brocker T
    J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
    Hill GR; Teshima T; Rebel VI; Krijanovski OI; Cooke KR; Brinson YS; Ferrara JL
    J Immunol; 2000 Jan; 164(2):656-63. PubMed ID: 10623807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
    Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG
    Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow.
    Nakamura K; Kouro T; Kincade PW; Malykhin A; Maeda K; Coggeshall KM
    J Exp Med; 2004 Jan; 199(2):243-54. PubMed ID: 14718513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
    Young KJ; DuTemple B; Phillips MJ; Zhang L
    J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.
    Coudert JD; Coureau C; Guéry JC
    J Immunol; 2002 Sep; 169(6):2979-87. PubMed ID: 12218112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.
    Richards DM; Dalheimer SL; Ehst BD; Vanasek TL; Jenkins MK; Hertz MI; Mueller DL
    J Immunol; 2004 Mar; 172(6):3469-79. PubMed ID: 15004147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
    Foucras G; Coudert JD; Coureau C; Guéry JC
    J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.